You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

Market Analysis and Insights: Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market
The global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Scope and Segment
The global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
TNF Inhibitors
Aminosalicylates
Integrin Antagonists
Corticosteroids
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the IBD (Ulcerative Colitis and Crohn's Disease) Treatment market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.
The IBD (Ulcerative Colitis and Crohn's Disease) Treatment key manufacturers in this market include:
AbbVie
Pfizer
Janssen Biotech,Inc.(Johnson&Johnson)
Allergan
Bausch Health Companies
Takeda Pharmaceutical Company
Novartis
Biogen
1 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Overview
1.1 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Product Overview
1.2 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Segment by Type
1.2.1 TNF Inhibitors
1.2.2 Aminosalicylates
1.2.3 Integrin Antagonists
1.2.4 Corticosteroids
1.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Type (2015-2026)
1.3.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size Overview by Type (2015-2026)
1.3.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size Forecast by Type (2021-2026)
1.3.3.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Breakdown by Type (2015-2026)
1.4.2 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Breakdown by Type (2015-2026)
1.4.4 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Breakdown by Type (2015-2026)

2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Competition by Company
2.1 Global Top Players by IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales (2015-2020)
2.2 Global Top Players by IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue (2015-2020)
2.3 Global Top Players IBD (Ulcerative Colitis and Crohn's Disease) Treatment Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers IBD (Ulcerative Colitis and Crohn's Disease) Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Competitive Situation and Trends
2.5.1 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBD (Ulcerative Colitis and Crohn's Disease) Treatment as of 2019)
2.7 Date of Key Manufacturers Enter into IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market
2.8 Key Manufacturers IBD (Ulcerative Colitis and Crohn's Disease) Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Status and Outlook by Region (2015-2026)
3.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size Market Share by Region (2015-2020)
3.2.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Region (2015-2020)
3.2.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Region (2015-2020)
3.2.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size Market Share by Region (2021-2026)
3.3.1 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Region (2021-2026)
3.3.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Region (2021-2026)
3.3.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
3.4.1 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue YoY Growth (2015-2026)
3.4.2 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales YoY Growth (2015-2026)
3.5 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales YoY Growth (2015-2026)
3.6 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
3.6.1 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue YoY Growth (2015-2026)
3.6.2 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales YoY Growth (2015-2026)
3.7 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
3.7.1 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue YoY Growth (2015-2026)
3.7.2 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales YoY Growth (2015-2026)
3.8 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales YoY Growth (2015-2026)

4 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
4.1 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales by Application: 2015 VS 2020 VS 2026
4.3 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Historic Sales by Application (2015-2020)
4.4 Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Forecasted Sales by Application (2021-2026)
4.5 Key Regions IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Application
4.5.1 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
4.5.2 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
4.5.3 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
4.5.4 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
4.5.5 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment by Application
5 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2015-2020)
5.1.2 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2021-2026)
5.2.2 North America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
5.3.2 Canada IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
6 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2015-2020)
6.1.2 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2021-2026)
6.2.2 Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
6.3.2 France IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
6.3.3 U.K. IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
6.3.4 Italy IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
6.3.5 Russia IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.2 Japan IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.3 South Korea IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.4 India IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.5 Australia IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.6 Taiwan IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.7 Indonesia IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.8 Thailand IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.9 Malaysia IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.10 Philippines IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
7.3.11 Vietnam IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
8 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2015-2020)
8.1.2 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2021-2026)
8.2.2 Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
8.3.2 Brazil IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
8.3.3 Argentina IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
9 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)
9.3.3 U.A.E IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in IBD (Ulcerative Colitis and Crohn's Disease) Treatment Business
10.1 AbbVie
10.1.1 AbbVie Corporation Information
10.1.2 AbbVie Description, Business Overview and Total Revenue
10.1.3 AbbVie IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.1.4 AbbVie IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.1.5 AbbVie Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Description, Business Overview and Total Revenue
10.2.3 Pfizer IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.2.4 AbbVie IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.2.5 Pfizer Recent Development
10.3 Janssen Biotech,Inc.(Johnson&Johnson)
10.3.1 Janssen Biotech,Inc.(Johnson&Johnson) Corporation Information
10.3.2 Janssen Biotech,Inc.(Johnson&Johnson) Description, Business Overview and Total Revenue
10.3.3 Janssen Biotech,Inc.(Johnson&Johnson) IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Janssen Biotech,Inc.(Johnson&Johnson) IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.3.5 Janssen Biotech,Inc.(Johnson&Johnson) Recent Development
10.4 Allergan
10.4.1 Allergan Corporation Information
10.4.2 Allergan Description, Business Overview and Total Revenue
10.4.3 Allergan IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Allergan IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.4.5 Allergan Recent Development
10.5 Bausch Health Companies
10.5.1 Bausch Health Companies Corporation Information
10.5.2 Bausch Health Companies Description, Business Overview and Total Revenue
10.5.3 Bausch Health Companies IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Bausch Health Companies IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.5.5 Bausch Health Companies Recent Development
10.6 Takeda Pharmaceutical Company
10.6.1 Takeda Pharmaceutical Company Corporation Information
10.6.2 Takeda Pharmaceutical Company Description, Business Overview and Total Revenue
10.6.3 Takeda Pharmaceutical Company IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.6.4 Takeda Pharmaceutical Company IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.6.5 Takeda Pharmaceutical Company Recent Development
10.7 Novartis
10.7.1 Novartis Corporation Information
10.7.2 Novartis Description, Business Overview and Total Revenue
10.7.3 Novartis IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.7.4 Novartis IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.7.5 Novartis Recent Development
10.8 Biogen
10.8.1 Biogen Corporation Information
10.8.2 Biogen Description, Business Overview and Total Revenue
10.8.3 Biogen IBD (Ulcerative Colitis and Crohn's Disease) Treatment Sales, Revenue and Gross Margin (2015-2020)
10.8.4 Biogen IBD (Ulcerative Colitis and Crohn's Disease) Treatment Products Offered
10.8.5 Biogen Recent Development

11 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 IBD (Ulcerative Colitis and Crohn's Disease) Treatment Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Porter’s Five Forces Analysis

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125